We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+27.62%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$1.02B
AUM Growth
+$268M
Cap. Flow
+$26.2M
Cap. Flow %
2.58%
Top 10 Hldgs %
33.11%
Holding
117
New
41
Increased
22
Reduced
19
Closed
29

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$17.4M
2
MRK icon
Merck
MRK
+$14.1M
3
NET icon
Cloudflare
NET
+$13.1M
4
FCX icon
Freeport-McMoran
FCX
+$12.9M
5
NVO
Novo Nordisk
NVO
+$12M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$28.8M
2
META icon
Meta Platforms (Facebook)
META
+$14.7M
3
FWONK icon
Liberty Media Series C
FWONK
+$13.9M
4
PDD icon
Pinduoduo
PDD
+$11.7M
5
ASML icon
ASML
ASML
+$8.7M

Sector Composition

Rank Sector Weight
1 Healthcare 32.83%
2 Technology 25.25%
3 Industrials 9.81%
4 Consumer Discretionary 7.9%
5 Materials 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRSP icon
76
CRISPR Therapeutics
CRSP
$5.17B
$3.27M 0.32%
+48,000
New +$3.44M
BECN
77
DELISTED
Beacon Roofing Supply, Inc.
BECN
$2.94M 0.29%
+30,000
New +$2.61M
FTNT icon
78
Fortinet
FTNT
$117B
$2.87M 0.28%
+42,000
New +$2.8M
MPT
79
PUT
Medical Properties Trust
MPT
$2.81B
$2.82M 0.28%
6,000
– –
TAST
80
DELISTED
Carrols Restaurant Group, Inc.
TAST
$2.74M 0.27%
+288,000
New +$2.66M
HCP
81
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$2.56M 0.25%
+95,000
New +$2.3M
JANX icon
82
Janux Therapeutics
JANX
$967M
$2.43M 0.24%
+64,500
New +$1.4M
BHVN icon
83
Biohaven
BHVN
$2.21B
$2.05M 0.2%
+37,500
New +$1.86M
LYV icon
84
Live Nation Entertainment
LYV
$42.1B
$1.8M 0.18%
+17,000
New +$1.61M
CABA icon
85
CALL
Cabaletta Bio
CABA
$455M
$1.71M 0.17%
+1,000
New +$21.5K
SILK
86
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1.5M 0.15%
+81,936
New +$1.3M
CALY
87
CALL
Callaway Golf Company
CALY
$3.14B
$1.13M 0.11%
+701
New +$9.96K
ABVX
88
Abivax
ABVX
$11.4B
$715K 0.07%
+49,993
New +$645K
ACHC icon
89
Acadia Healthcare
ACHC
$2.94B
– –
-75,000
Closed -$5.83M
ADPT icon
90
Adaptive Biotechnologies
ADPT
$3.97B
– –
-330,000
Closed -$1.62M
AI icon
91
PUT
C3.ai
AI
$1.59B
– –
-250
Closed -$718K
AKRO
92
DELISTED
Akero Therapeutics
AKRO
– –
-79,935
Closed -$1.87M
AMD icon
93
CALL
Advanced Micro Devices
AMD
$789B
– –
-790
Closed -$11.6M
ARKG icon
94
ARK Genomic Revolution ETF
ARKG
$1.73B
– –
-109,089
Closed -$3.58M
ASML icon
95
ASML
ASML
$669B
– –
-11,500
Closed -$8.7M
AVY icon
96
Avery Dennison
AVY
$13.4B
– –
-35,500
Closed -$7.18M
BATRK icon
97
Atlanta Braves Holdings Series B
BATRK
$3.21B
– –
-191,000
Closed -$7.56M
BBIO icon
98
BridgeBio Pharma
BBIO
$16.5B
– –
-9,000
Closed -$306K
BILL icon
99
BILL Holdings
BILL
$4.78B
– –
-77,000
Closed -$6.28M
BMRN icon
100
BioMarin Pharmaceuticals
BMRN
$12.4B
– –
-85,000
Closed -$8.2M
1 2 3
4
5

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
SC
Soundwatch Capital Rowayton, Connecticut $793M AUM 15.45% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
VCM
Vision Capital Management Portland, Oregon $792M AUM 18.17% 1-Year Est. Return

Atika Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Atika Capital Management held 117 positions worth $1.02B, up 36% from $747M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Atika Capital Management's Q1 2024 filing shows 41 new, 22 increased, 19 reduced and 29 closed positions. Its largest new stake was Merck: 114,000 shares worth $15M. The largest sale was Advanced Micro Devices, an estimated $28.8M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

  • Atika Capital Management's largest Q1 2024 buy was Merck: 114,000 shares worth $15M.
  • Atika Capital Management added most to NVIDIA in Q1 2024, an estimated $17.4M increase.
  • Atika Capital Management's biggest Q1 2024 reduction was Advanced Micro Devices, cutting an estimated $28.8M.
  • Atika Capital Management fully exited Liberty Media Series C in Q1 2024, selling an estimated $13.9M.
  • Atika Capital Management's ten largest holdings make up 33% of its $1.02B portfolio in Q1 2024.
  • Atika Capital Management opened 41 new positions and closed 29 in Q1 2024.
  • Atika Capital Management's portfolio value rose 36% quarter-over-quarter to $1.02B.

Based on Atika Capital Management's 13F filing for Q1 2024, filed 14 May 2024.